Effect of aprotinin on smooth muscle cell proliferation, migration, and extracellular matrix synthesis

被引:13
作者
Horodyski, J
Powell, RJ
机构
[1] Section of Vascular Surgery, Yale University School of Medicine, New Haven
关键词
D O I
10.1006/jsre.1996.0381
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aprotinin (AP) is a plasmin inhibitor commonly used to limit bleeding during reoperative coronary bypass surgery. The effect on smooth muscle cell (SMC) behavior and the development of intimal hyperplasia has not been evaluated. This study examines the effect of AP on SMC proliferation, migration, and extracellular matrix synthesis. Bovine aortic SMCs (three to five passages) plated at 5 x 10(4) cells/ml were treated with 1.0, 10, 100, and 1000 mu g/ml AP. Proliferation was measured as micrograms of DNA per well, after 3 days in culture. SMC migration was measured after treatment with mitomycin C (20 mu g/ml, to study migration in the absence of proliferation) by means of a fence assay. Extracellular matrix was quantitated utilizing a tritiated proline assay and corrected for cell density (cpm/mu g DNA). Data are presented as means +/- SEM; ANOVA and post hoc Tuckey test were used to test for significant differences. AP stimulated SMC proliferation at dosages of 100 mu g/ml (353 +/- 6 mu g DNA, SMC control vs 440 +/- 11, 100 mu g/ml; P < 0.05) and 1000 mu g/ml (353 +/- 6, SMC control vs 503 +/- 14, 1000 mu g/ml; P < 0.01). AP concentrations less than 100 mu g/ml had no effect on SMC proliferation. A dose-response relationship existed between AP and SMC migration. AP doses as low as 10 mu g/ml increased SMC migration from 66 +/- 4 mm(2) (control SMC) to 90 +/- 4 mm(2) (P < 0.02) while the maximal dose of AP (1000 mu g/ml) produced an almost twofold increase in migration (66 +/- 4, SMC control vs 113 +/- 3, 1000 mu g/ml group; P < 0.0001). AP had no effect on extracellular matrix synthesis. AP stimulated vascular SMC migration and proliferation but not matrix synthesis in vitro. These data suggest that AP could augment the development of intimal hyperplasia following bypass surgery. (C) 1996 Academic Press
引用
收藏
页码:115 / 118
页数:4
相关论文
共 19 条
[1]  
ARKY R, 1996, PHYSICIANS DESK REFE, P613
[2]   PHENOTYPE RELATED CHANGES OF INTIMAL SMOOTH-MUSCLE CELLS FROM HUMAN AORTA IN PRIMARY CULTURE [J].
BABAEV, VR ;
ANTONOV, AS ;
DOMOGATSKY, SP ;
KAZANTSEVA, IA .
ATHEROSCLEROSIS, 1992, 96 (2-3) :189-202
[3]   SYNTHESIS AND EXPRESSION OF SMOOTH-MUSCLE PHENOTYPE MARKERS IN PRIMARY CULTURE OF RABBIT AORTIC SMOOTH-MUSCLE CELLS - INFLUENCE OF SEEDING DENSITY AND MEDIA AND RELATION TO CELL CONTRACTILITY [J].
BIRUKOV, KG ;
FRID, MG ;
ROGERS, JD ;
SHIRINSKY, VP ;
KOTELIANSKY, VE ;
CAMPBELL, JH ;
CAMPBELL, GR .
EXPERIMENTAL CELL RESEARCH, 1993, 204 (01) :46-53
[4]  
BLAUHUT B, 1991, J THORAC CARDIOV SUR, V101, P958
[5]   IMPROVED MICRO-FLUOROMETRIC DNA DETERMINATION IN BIOLOGICAL-MATERIAL USING 33258-HOECHST [J].
CESARONE, CF ;
BOLOGNESI, C ;
SANTI, L .
ANALYTICAL BIOCHEMISTRY, 1979, 100 (01) :188-197
[6]  
HAVEL M, 1991, J THORAC CARDIOV SUR, V101, P968
[7]  
KENAGY R, 1994, ANN NY ACAD SCI, V732, P463
[8]  
KOCHER O, 1991, LAB INVEST, V65, P459
[9]   PHARMACOKINETICS OF APROTININ IN PREOPERATIVE CARDIAC SURGICAL PATIENTS [J].
LEVY, JH ;
BAILEY, JM ;
SALMENPERA, M .
ANESTHESIOLOGY, 1994, 80 (05) :1013-1018
[10]   PROTEOLYTIC ACTIVATION OF LATENT TRANSFORMING GROWTH FACTOR-BETA FROM FIBROBLAST-CONDITIONED MEDIUM [J].
LYONS, RM ;
KESKIOJA, J ;
MOSES, HL .
JOURNAL OF CELL BIOLOGY, 1988, 106 (05) :1659-1665